EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

B7H4 Role in Solid Cancers: A Review of the Literature

Miriam Dawidowicz, Anna Kot, Sylwia Mielcarska, Katarzyna Psykała, Agnieszka Kula, Dariusz Waniczek iD, Elżbieta Świętochowska

Cancers · 11.07.2024 · 16 (14) · 2519

DOI: 10.3390/cancers16142519 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 11.07.2024. Verfasst von Miriam Dawidowicz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncological Surgery, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808 Katowice, Poland. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anti-cancer immunotherapies entirely changed the therapeutic approach to oncological patients. However, despite the undeniable success of anti-PD-1, PD-L1, and CTLA-4 antibody treatments, their effectiveness is limited either by certain types of malignancies or by the arising problem of cancer resistance. B7H4 (aliases B7x, B7H4, B7S1, VTCN1) is a member of a B7 immune checkpoint family with a distinct expression pattern from classical immune checkpoint pathways. The growing amount of research results seem to support the thesis that B7H4 might be a very potent therapeutic target. B7H4 was demonstrated to promote tumour progression in immune “cold” tumours by promoting migration, proliferation of tumour cells, and cancer stem cell persistence. B7H4 suppresses T cell effector functions, including inflammatory cytokine production, cytolytic activity, proliferation of T cells, and promoting the polarisation of naïve CD4 T cells into induced Tregs. This review aimed to summarise the available information about B7H4, focusing in particular on clinical implications, immunological mechanisms, potential strategies for malignancy treatment, and ongoing clinical trials.

Schlagwörter

Stichwörter der Autor:innen

B7 familyB7H4immune checkpointimmunological tumour microenvironmentimmunotherapy

Autor:innen und Institutionen

  • Department of Oncological Surgery, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 41-808 Katowice, Poland.
  • Department of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 19 Jordana, 41-800 Zabrze, Poland.

ORCID-Profile: Dariusz Waniczek

Zitieren

APA

Dawidowicz, M., Kot, A., Mielcarska, S., Psykała, K., Kula, A., Waniczek, D., & Świętochowska, E. (2024). B7H4 Role in Solid Cancers: A Review of the Literature. Cancers, 16(14), 2519. https://doi.org/10.3390/cancers16142519

Vancouver

Dawidowicz M, Kot A, Mielcarska S, Psykała K, Kula A, Waniczek D, et al. B7H4 Role in Solid Cancers: A Review of the Literature. Cancers. 2024;16(14):2519. doi:10.3390/cancers16142519

BibTeX
@article{Dawidowicz2024,
  author = {Dawidowicz, Miriam and Kot, Anna and Mielcarska, Sylwia and Psykała, Katarzyna and Kula, Agnieszka and Waniczek, Dariusz and Świętochowska, Elżbieta},
  title = {B7H4 Role in Solid Cancers: A Review of the Literature},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {14},
  pages = {2519},
  doi = {10.3390/cancers16142519}
}
Kostenlos starten →